Can Heavy School Bags Cause Scoliosis?
With schools reopening soon, it is time again for children to lug their heavy bags after almost two years of...
Iskandar Shahril
Lunit AI Receives HSA Approval, Now Commercially Available in Singapore
Lunit recently announced its AI products for analysing chest X-ray 'Lunit INSIGHT CXR' and breast mammography 'Lunit INSIGHT MMG' have...
Coway Contributes 101 Air Purifiers to Mega Vaccination Centres
In efforts to bolster Malaysia’s National COVID-19 Immunisation Programme (NIP), Coway Malaysia recently contributed 101 units of Coway air purifiers,...
Aurelius Healthcare Group Acquires Nilai Medical Centre
Aurelius Healthcare Sdn. Bhd. (“Aurelius”), a new healthcare group which aspires to be the leading healthcare management platform in the...
Managing Mental Health and Well-Being During the COVID-19 Pandemic
This article is contributed by Yap Chee Khong, Clinical Psychologist, Sunway Medical Centre, and does not represent the views or...
CanSurvive Organises 11th International Conference on Holistic Healing from Cancer
CanSurvive Centre Malaysia Berhad, a non-profit cancer charity organisation, announces its 11th International Conference on Holistic Healing from Cancer”, which...
Alpro Foundation Collaborates with Award-Winning Savant Artist to Raise Funds for The Autism Community in Malaysia
Alpro Foundation, the charity arm of Malaysia’s largest prescription pharmacy chain, Alpro Pharmacy, has collaborated with acclaimed Malaysian savant artist,...
AstraZeneca: Forxiga Approved in Japan for the Treatment of Chronic Kidney Disease in Patients With and Without Type-2 Diabetes
AstraZeneca’s Forxiga (dapagliflozin), a sodium-glucose cotransporter 2 (SGLT2) inhibitor, has been approved in Japan for the treatment of chronic kidney...
ASEAN-Focused Dental Group, Oracare Group, Formed with Plans to Accelerate Expansion Across Southeast Asia
Singapore-based Oracare Group ("Oracare"), one of the largest dental groups in Southeast Asia, is the new holding company and international...
Viracta Therapeutics Reacquires Exclusive Development and Commercialization Rights for its All-Oral Combination Therapy in China
Viracta Therapeutics, Inc., a precision oncology company targeting virus-associated malignancies, today announced that it has reacquired the exclusive rights to...
